{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T03:13:21Z","timestamp":1789442001568,"version":"build-2803163510"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>The efficacy of botulinum toxin A (BTX-A) therapy in axillary hyperhidrosis has been documented; however, there are a few studies reporting the efficacy of BTX-A in treating axillary bromhidrosis. The histological changes occurring in sweat glands after BTX-A treatment are also unknown.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>The authors report on the efficacy and safety of BTX-A in the treatment of axillary bromhidrosis and on the histological changes in sweat glands after BTX-A treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MATERIALS AND METHODS<\/jats:title>\n            <jats:p>Nineteen patients were included in this study. The patients were administered BTX-A injection in one axilla and sterile normal saline as placebo in the other axilla. The degree of malodor was evaluated subjectively by the patients before and 3 months after treatment. Sweat secretion was quantified by the gravimetric method. All patients underwent standard apocrinectomy in both axillary regions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>The mean degree of malodor and mean sweat production in the BTX-A\u2013treated axilla were significantly lower than those in the control axilla (2.42 vs 8.00; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; .0001 and 13.33 vs 33.75 mg\/min; <jats:italic toggle=\"yes\">p<\/jats:italic> = .0028, respectively) at 3 months after therapy. The histological studies showed apocrine sweat glands with atrophic changes and hypoplasia in treated axilla.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>BTX-A injection is an easy, fast, noninvasive method of treating axillary bromhidrosis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000001906","type":"journal-article","created":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T04:23:13Z","timestamp":1552450993000},"page":"1605-1609","source":"Crossref","is-referenced-by-count":29,"title":["Efficacy and Safety of Botulinum Toxin A in Axillary Bromhidrosis and Associated Histological Changes in Sweat Glands: A Prospective Randomized Double-Blind Side-by-Side Comparison Clinical Study"],"prefix":"10.1097","volume":"45","author":[{"given":"Chien-Ju","family":"Wu","sequence":"first","affiliation":[{"name":"Division of Plastic Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Kai","family":"Chang","sequence":"additional","affiliation":[{"name":"Division of Plastic Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Yu","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Plastic Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Shu","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyi-Gen","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Plastic Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230814","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0007-1226(97)91285-6","article-title":"Excision of subcutaneous tissue for the treatment of axillary osmidrosis","volume":"50","author":"Tung","year":"1997","journal-title":"Br J Plast Surg"},{"key":"R2-20230814","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.clindermatol.2015.04.013","article-title":"Hyperhidrosis, bromhidrosis, and chromhidrosis: fold (intertriginous) dermatoses","volume":"33","author":"Semkova","year":"2015","journal-title":"Clin Dermatol"},{"key":"R3-20230814","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00266-011-9738-4","article-title":"Treatment of axillary hyperhidrosis with botulinum toxin: a single surgeon's experience with 53 consecutive patients","volume":"35","author":"Doft","year":"2011","journal-title":"Aesthet Plast Surg"},{"key":"R4-20230814","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/pde.12620","article-title":"A prospective, nonrandomized, open-label study of the efficacy and safety of OnabotulinumtoxinA in adolescents with primary axillary hyperhidrosis","volume":"32","author":"Glaser","year":"2015","journal-title":"Pediatr Dermatol"},{"key":"R5-20230814","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1111\/jdv.13219","article-title":"Treatment of axillary osmidrosis: a comparison between subcutaneous laser and superficial liposuction curettage","volume":"29","author":"Chen","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R6-20230814","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/1574-6941.12054","article-title":"Microbiological and biochemical origins of human axillary odour","volume":"83","author":"James","year":"2013","journal-title":"FEMS Microbiol Ecol"},{"key":"R7-20230814","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.bjps.2009.05.004","article-title":"Effectiveness and complications of subdermal excision of apocrine glands in 206 cases with axillary osmidrosis","volume":"63","author":"Qian","year":"2010","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R8-20230814","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/DSS.0000000000000346","article-title":"Excision of apocrine glands with preservation of axillary superficial fascia for the treatment of axillary bromhidrosis","volume":"41","author":"Li","year":"2015","journal-title":"Dermatol Surg"},{"key":"R9-20230814","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.bjps.2005.10.012","article-title":"Radical treatment of axillary osmidrosis by subdermal excision of apocrine glands: a prospective study in 31 cases","volume":"59","author":"Qian","year":"2006","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R10-20230814","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1016\/j.bjps.2013.01.029","article-title":"Treatment of axillary osmidrosis with the use of Versajet","volume":"66","author":"Kim","year":"2013","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R11-20230814","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1365-4632.2008.03735.x","article-title":"Etiology and management of axillary bromidrosis: a brief review","volume":"47","author":"Mao","year":"2008","journal-title":"Int J Dermatol"},{"key":"R12-20230814","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1524-4725.1992.tb03295.x","article-title":"Treatment of glabellar frown lines with C: botulinum-A exotoxin","volume":"18","author":"Carruthers","year":"1992","journal-title":"J Dermatol Surg Oncol"},{"key":"R13-20230814","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/mds.20403","article-title":"Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study","volume":"20","author":"Truong","year":"2005","journal-title":"Mov Disord"},{"key":"R14-20230814","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/archopht.1985.01050030043017","article-title":"Botulinum A toxin injection as a treatment for blepharospasm","volume":"103","author":"Scott","year":"1985","journal-title":"Arch Ophthalmol"},{"issue":"Suppl 8","key":"R15-20230814","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1002\/mds.20065","article-title":"Physiological effects of botulinum toxin in spasticity","volume":"19","author":"Gracies","year":"2004","journal-title":"Mov Disord"},{"issue":"Suppl 1","key":"R16-20230814","first-page":"44","article-title":"First results of clinical studies on botulinum toxin A in migraine and headache [in German]","volume":"79","author":"Tiesler","year":"2008","journal-title":"Nervenarzt"},{"key":"R17-20230814","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2147\/NDT.S1612","article-title":"Neurologic uses of botulinum neurotoxin type A","volume":"3","author":"Ney","year":"2007","journal-title":"Neuropsychiatr Dis Treat"},{"key":"R18-20230814","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0168-6054(03)00103-X","article-title":"Sialorrhea, hyperhidrosis and botulinum toxin [in French]","volume":"46","author":"Monnier","year":"2003","journal-title":"Ann Readapt Med Phys"},{"key":"R19-20230814","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1067\/mjd.2000.105567","article-title":"Pharmacology of botulinum toxin","volume":"43","author":"Huang","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"R20-20230814","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archderm.139.1.57","article-title":"Amelioration of body odor after intracutaneous axillary injection of botulinum toxin A","volume":"139","author":"Heckmann","year":"2003","journal-title":"Arch Dermatol"},{"key":"R21-20230814","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1365-2230.2003.01162.x","article-title":"Axillary hyperhidrosis: eccrine or apocrine?","volume":"28","author":"Lonsdale-Eccles","year":"2003","journal-title":"Clin Exp Dermatol"},{"key":"R22-20230814","first-page":"R181","article-title":"Sweat secretion by human axillary apoeccrine sweat gland in vitro","volume":"252","author":"Sato","year":"1987","journal-title":"Am J Physiol"},{"key":"R23-20230814","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s00266-018-1075-4","article-title":"Long-term safety and efficacy of botulinum toxin a treatment in adolescent patients with axillary bromhidrosis","volume":"42","author":"Wang","year":"2018","journal-title":"Aesthet Plast Surg"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000001906","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T20:03:20Z","timestamp":1692043400000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000001906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000001906","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]}}}